Informa to sell its pharma analytics unit to Warburg for £1.9bn
Shares in the world's largest exhibitions group rose as much as 5.4% to their highest level since November 2020 off the back of Thursday's announcement.
Source: dailymail.co.uk
Page 22 - Pharma Intelligence News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Intelligence Today - Breaking & Trending Today
LONDON MARKET CLOSE: FTSE climbs but New York weaker after hot US CPI
LONDON MARKET CLOSE: FTSE climbs but New York weaker after hot US CPI | Financial News
Source: lse.co.uk
Capitalising on global biosimilar opportunity
The potential demand for biosimilars undoubtedly generates an enormous opportunity for biopharmaceutical companies. However, biosimilar development and commercialiszation is an inimitably complex endeavour requiring a precise, stepwise strategy to ensure timely regulatory approval and optimum market access. Even companies that are aiming to protect the market share of a branded biologic product are compelled to adapt to the increased competition from biosimilars. Given these dynamics, the uniqueness of biosimilars necessitates that an integrated, strategic development and commercial plan must ...
Source: biospectrumindia.com
CORRECTION - Americans Push for Rapid Pharma Innovation:
New report from Informa Pharma Intelligence finds Americans are closely watching COVID-19 vaccine and treatment clinical trials as the U.S. continues to...
Source: globenewswire.com
Andrew Lo Wants to Predict Clinical-Trial Outcomes, Cut Drug Costs
Developing drugs can take almost $1 billion and works only 9% of the time. MIT professor Andrew Lo wants to change that.
Source: businessinsider.com